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Abstract
A collection of 30 DHA-1-Enterobacteriaceae producers was
examined for the presence of qnr genes. PCR-based replicon
typing, plasmid proﬁle and Southern hybridisation analyses
revealed that all isolates co-harboured blaDHA-1 and qnrB genes
on the same plasmid. All but one of these plasmids belonged to
the L/M group. Genetic organization analyses of a randomly
selected isolate revealed the co-localization of both genes on an
IS26-composite transposon. As plasmids carrying both genes
seem to have a high prevalence and a worldwide distribution,
care should be taken when quinolones are used to treat infec-
tions caused by DHA-1 producers.
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DHA-1, an inducible acquired AmpC enzyme conferring
resistance to most b-lactamams, and QnrB, a plasmid-medi-
ated enzyme conferring low resistance to quinolones, have
been widely associated with clinical isolates of the family
Enterobacteriaceae [1,2]. Although these enzymes were ﬁrst
described in 1992 and 2006, respectively [3,4], it was not
until some years later that their presence noticeably
increased, and they became the most prevalent enzymes of
their groups in some countries [1,5,6]. As a strong correla-
tion has been reported between these two resistance mech-
anisms [6], the aim of this study was to analyse the presence
of qnr genes on a large characterized collection of DHA-1-
Enterobacteriaceae producers to determine whether they
were localized on the same or different plasmids. As in some
cases blaDHA-1 and qnrB genes have been linked together on
a complex sul1-type integron [7], we also analysed their
genetic organization on the plasmid.
A total of 30 Enterobacteriaceae lacking inducible chromo-
somal ampC genes encoding blaDHA-1 or blaDHA-1 plus
blaCTX-M-14,-15 were collected from a Spanish hospital (Hospi-
tal de la Santa Creu i Sant Pau, Barcelona) from 2005 to
2007 [8]. Bacterial isolates were mainly recovered from
urine (76.7%) and most of them (83.3%) were from patients
aged 70 to 95 years old. Occurrence of these resistance
determinants increased over this period from six cases in
2005 to 16 cases in 2007 [8]. No clonal relationship was
established between these isolates except for one cluster of
two E. coli, one cluster of two K. pneumoniae co-producing
DHA-1 plus CTX-M-15 and one cluster of two K. oxytoca
[8].
Using the broth mating method [9], transfer of blaDHA-1
genes via conjugation was possible in 86.7% (26/30) of the
tested strains, with a conjugation frequency ranging from
10)5 to 10)8 transconjugants per recipient. Transconjugants
were selected on LB agar supplemented with ceftazidime
(10 mg/L) and rifampin (100 mg/L). Among the ﬁve isolates
co-harbouring blaDHA-1 plus blaCTX-M14,-15 genes, both resis-
tant determinants were transferred in three of them (101-
Tc, 103-Tc and 104-Tc) (Table 1).
Antibiotic agents used in the disc diffusion susceptibility
test in donor and transconjugant strains are listed in Table 1.
All donor and transconjugant strains showed high-level resis-
tance to most b-lactam antibiotic agents, as expected by an
ampC-producer. Antibiotics displaying higher activity against
AmpC b-lactamases were imipenem, cefepime and aztreo-
nam, with percentages of susceptible isolates of 100%, 92.3%
and 84.6%, respectively (data not shown). These isolates also
showed reduced susceptibility to other antibiotic families
(Table 1). Non-b-lactam antibiotics transferred via conjuga-
tion were nalidixic acid (61.5%), sulphonamides (30.8%),
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trimethoprim (15.4%), tetracycline (11.5%) and trimetho-
prim-sulphamethoxazole (7.7%) (Table 1).
Screening of qnr genes in all 30 isolates was carried out by
PCR ampliﬁcation [10]. qnrB genes were present in all iso-
lates tested. These results were in agreement with other
reports that found a close association between qnrB, espe-
cially qnrB4, and blaDHA-1 determinants in isolates of the fam-
ily Enterobacteriaceae [6,11–13].
PCR-based replicon typing, plasmid proﬁle and Southern
hybridization analyses were performed in all 30 DHA-1 pro-
ducers (Table 1) as previously described [9]. Two of these
isolates were lysed during the S1-PFGE and therefore could
not be analysed. To determine whether both resistance genes
were localized on the same or different plasmids, hybridiza-
tion with blaDHA-1 and qnrB probes was performed. Results
revealed the co-localization of blaDHA-1 and qnrB resistance
genes on the same conjugative plasmid in all 28 isolates tested
(Table 1). All but one of the plasmids associated with qnrB,
blaDHA-1 or blaDHA-1 plus blaESBL belonged to the broad-host-
range L/M plasmids (Table 1), while blaDHA-1 has traditionally
been found on narrow-host-range IncFII plasmids [14]. The
single isolate not linked to the IncL/M group, carried both
resistance genes on an IncN plasmid. This is the ﬁrst time that
both blaDHA-1 and qnrB genes have been described on an IncN
plasmid [14]. The new localization of blaDHA-1 and qnrB4
genes in broad-host-range L/M plasmids has been postulated
as a possible cause of the lately widespread distribution of
blaDHA-1 genes [9]. Our results reinforce this idea, together
with the fact that a strong association between qnrB and
blaDHA-1 has been evidenced worldwide [2,6,7,15] and that
recent reports have found blaDHA-1 and qnrB genes also in L/
M plasmids [16].
The genetic organization of these 30 isolates carrying
blaDHA-1 has been previously analysed by overlapping PCR
ampliﬁcation, exploring the most frequent regions surround-
ing ampC genes described in the literature (data not shown).
As 93.3% (28/30) of the isolates displayed the same genetic
organization, an IS26 element and a region from the Morga-
nella morganii genome found upstream and downstream of
blaDHA-1, respectively, one of them was randomly selected
TABLE 1. Non-b-lactam resistance proﬁles in donor and transconjugant strains, location of bla and qnrB genes and plasmid
size
Strains-D/Tca Species
Isolation
datab
Non-b-lactam resistance proﬁlec
Replicon typing/resistant
enzymes/plasmid size (kb)dDonors Transconjugants
35-Tc E. coli 01/05 SSS,SXT, TET, NAL, CIP SSS L/M-FIADHA)1,QnrB (171)
36-Tc E. coli 06/05 SSS, TET NAL L/MDHA)1,QnrB (209)
37-Tc E. coli 07/05 SSS, TMP, SXT, TET, NAL, CIP SSS, NAL L/MDHA)1,QnrB (100 and 312)e
38-Tc E. coli 12/05 SSS, TMP, SXT, NAL, CIP – L/MDHA)1,QnrB (79)
62-Tc E. coli 06/06 SSS, TMP, SXT, TET, CHL, NAL, CIP SSS, NAL L/MDHA)1,QnrB (74 and 164)e
63-Tc E. coli 07/06 NAL, CIP NAL L/MDHA)1,QnrB (293)
64-D E. coli 12/06 – – F, FIB (lysed)
95-Tc E. coli 01/07 NAL NAL L/MDHA)1,QnrB (236)
96-Tc E. coli 06/07 SSS, TMP, SXT, NAL, CIP NAL L/MDHA)1,QnrB (96)
97-Tc E. coli 07/07 SSS, TET, CHL, NAL, CIP NAL L/MDHA)1,QnrB (173)
98-Tc E. coli 07/07 TET, NAL, CIP TET, NAL NDHA)1,QnrB (52)
99-Tc E. coli 08/07 SSS, TMP, SXT, TET, NAL, CIP NAL L/M-FIADHA)1,QnrB (155)
100-D E. coli 07/07 SSS, TMP, SXT, TET, NAL, CIP – L/M, F, FIB (lysed)
101-Tc E. coli 09/07 NAL NAL L/MDHA)1,QnrB (156), I1/IcCTX-M)14 (88)
102-Tc E. coli 12/07 SSS, TMP, SXT, TET, NAL, CIP TMP, TET, NAL L/MDHA)1,QnrB (93), F-FIB (148)
40-D K. pneumoniae 01/05 – – L/MDHA)1,QnrB (79)
41-Tc K. pneumoniae 06/05 NAL NAL L/MDHA)1,QnrB (202)
66-D K. pneumoniae 08/06 TMP, CHL, NAL – L/MDHA)1,QnrB (72)
67-Tc K. pneumoniae 10/06 – – L/MDHA)1,QnrB (72)
103-Tc K. pneumoniae 02/07 TMP, NAL, CIP TMP, SXT L/MDHA)1,QnrB,CTX-M)15 (168)
104-Tc K. pneumoniae 03/07 TMP, NAL, CIP TMP L/M-FICDHA)1,QnrB,CTX-M)15 (153)
105-Tc K. pneumoniae 06/07 SSS, TMP, SXT, TET, CHL, NAL, CIP – L/MDHA)1,QnrB (72)
106-Tc K. pneumoniae 06/07 NAL NAL L/MDHA)1,QnrB (72)
107-Tc K. pneumoniae 08/07 NAL, CIP – L/MDHA)1,QnrB (72)
108-Tc K. pneumoniae 10/07 SSS, TMP, SXT, TET, CHL, NAL, CIP – L/MDHA)1,QnrB (70)
68-Tc K. oxytoca 11/06 – – L/MDHA)1,QnrB (72)
69-Tc K. oxytoca 12/06 SSS, TMP, SXT, TET – L/MDHA)1,QnrB (72)
109-Tc K. oxytoca 06/07 SSS, TMP, SXT, TET, NAL, CIP NAL L/M-FICDHA)1,QnrB (153)
110-Tc K. oxytoca 08/07 NAL NAL L/MDHA)1,QnrB (112)
77-Tc P. mirabilis 10/06 SSS, TMP, SXT, TET, NAL, CIP SSS, TMP, SXT, TET, NAL L/M-NDHA)1,QnrB (103)
Ampicillin, piperacillin, cephalotin, cefuroxime, cefotaxime, ceftazidime, cefepime, aztreonam, cefoxitin, amoxicillin-clavulanic acid, piperacillin-tazobactam and imipenem were
also used for susceptibility testing. As the recipient used for conjugation was resistant to aminoglycoside antibiotics, this antibiotic family was not included in the study.
NAL, nalidixic acid; CIP, ciproﬂoxacin; SSS, sulphonamides; TMP, trimethoprim; SXT, trimethoprim-sulfamethoxazole; TET, tetracycline; CHL, chloramphenicol.
aNames assigned to the strains. D, donor strains due to the inability to obtain transconjugants; Tc, transconjugant strains.
bIsolation date of donor strains (month/year).
cThe disc diffusion susceptibility test was performed according to Clinical Laboratory Standards Institute (CLSI) guidelines. All transconjugant strains resistant to NAL dis-
played reduced susceptibility (14–18 mm; intermediate as clinical category).
dPlasmid analyses results given are from transconjugant strains with the exception of 40-D, 64-D, 66-D and 100-D due to the inability to obtain transconjugants in these iso-
lates.
eblaDHA-1, L/M replicon and qnrB probes hybridized in both plasmids present in this isolate.
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for further analyses. Plasmid extraction of this E. coli isolate
was performed. Isolated plasmids were sequenced by Euro-
ﬁns MWG Operon using GS FLX Titanium series chemistry
technology. Partial analysis of the sequenced plasmid, called
pEC37Tc, showed that blaDHA-1 and qnrB4 were localized
together on an IS26-composite transposon, most likely
involved in their mobilization (Fig. 1). Other non-resistance
genes found in this structure were the 3¢CS extreme of a
class 1 integron and the stress-inducible psp (phage shock
protein) operon (Fig. 1). Under a wide variety of environ-
mental signals, the psp operon is highly transcribed to con-
serve membrane integrity, efﬁcient translocation and
maintenance of the proton motive force [17]. This structure,
carrying beneﬁcial traits to the bacteria such as antibiotic
resistance genes and a wide response to environmental fac-
tors, may contribute to the maintenance of the plasmid in
the bacteria. Linkage of blaDHA-1 and qnrB4 genes on similar
structures has so far been described in isolates of Klebsiella
spp, mainly K. pneumoniae [7,18,19]. To our knowledge, this
is the ﬁrst time that this genetic organization is described in
an E. coli strain.
The presence of qnr genes has been associated with an
increase in the quinolone MIC values and treatment failures
when quinolones are used to treat quinolone-susceptible
enterobacteria [15]. As plasmids carrying both resistance deter-
minants seem to have a high prevalence and a worldwide dis-
tribution, care should be taken when quinolones are used to
treat infections caused by DHA-1-Enterobacteriaceae producers.
Nucleotide Sequence Accession Number
The GenBank accession number of the sequence presented
here is HQ700359 (pEC37Tc).
pTN60013 (K. pneumoniae)
1 kb 
pPMDHA (K. oxytoca)
Deletion at the 3′end 
IS26 partial sapB sapA qnrB4 F A B C D blaDHA-1 ampR qacE¨1sul1
Phage shock protein pHS7 and pKP1212/05-1 (K. pneumoniae)
ISCR1 sapC¨3′ sapB sapA F  A  B C D blaDHA-1 ampR qacE¨1sul1 orf5¨3′ IS4321
Phage shock protein 
pRBDHA (K. pneumoniae) 
 
ISCR1 sapC¨3′ sapB sapA F A   B C D blaDHA-1 ampR qacE¨1sul1 orf5  IS26
Phage shock protein 
Partial IS26 qnrB4 F A B C D blaDHA-1 ampR
Phage shock protein 
pEC37Tc (E. coli) 
Partial IS26 F A B  C D blaDHA-1 ampR qacE¨1sul1 orf5  IS26
Phage shock protein 
orf5 IS26qacE¨1sul1
FIG. 1 Genetic organization of pEC37Tc in comparison with the common regions of other plasmids carrying blaDHA-1 and qnrB genes. GenBank
accession numbers of pRBDHA, pMPDHA, pHS7, pKP1212/05-1, pTN60013 and pEC37Tc are AJ971343, AJ971344, EF683583, FJ943500,
AJ971345 and HQ700359, respectively. Genes are represented by arrows. The resistant genes qnrB4 and blaDHA-1 are represented by ﬁlled
arrows. Insertion sequences are represented by black arrows. Shaded regions are regions of 100% identity. Although qnrB4 genes are present in
all the plasmids shown, the arrow for this gene is not drawn in pRBDHA, pMPDHA and pTN60013 because it is not annotated in the submitted
GenBank sequence.
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Enhanced isolation of Legionella species
from composted material
S. McCabe, A. Brown, G. F. S. Edwards and D. Lindsay
Scottish Haemophilus Legionella Meningococcus Pneumococcus Reference
Laboratory (SHLMPRL), House on the Hill, Stobhill Hospital, Glasgow, UK
Abstract
Legionella pneumophila and Legionella species were isolated from
composted material when freshly prepared buffered charcoal
yeast extract (BCYE) was supplemented with glycine (1.5 g/L),
polymyxin B sulfate (40 000 IU/L), vancomycin hydrochloride
(0.5 mg/L) and cycloheximide (40 mg/L) (GVPC medium) and
Modiﬁed Wadowsky–Yee (MWY) (Oxoid, Cambridge, UK)
plates were used for cultivation, but not with commercially
sourced pre-poured GVPC and MWY plates (Oxoid). Legionella
cincinnatiensis and pathogenic L. pneumophila serogroup (Sg) 1
Benidorm and France/Allentown were identiﬁed, as well as a
non-typeable (NT) strain of L. pneumophila. As most laboratories
no longer produce their own media, this may contribute to the
lack of positive cultures from composted material. The antigenic-
ity of the NT strain is discussed.
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